Brown & Brown, Inc. (BRO)
Financiero / Corretaje de seguros
Brown & Brown is a national-scale insurance broker (Retail and Specialty Distribution) that places third-party premiums without assuming underwriting risk; the transformational Accession acquisition in 2025 roughly doubled its size but pushed debt to nearly US$7,800 million just as organic growth turned negative in the first half of 2026, in a softening insurance pricing market. It trades close to intrinsic value, far from the required margin of safety.
- Price
- $73.34
- Intrinsic value (5y, base)
- $109
- Total annual return (5y)
- 9.3%
- Status (nominal)
- Fairly valued
- Margin of safety
- +20%
The essentials
- Asset-light intermediation model: it does not assume underwriting risk on the bulk of the business, earning commission on placed premium plus fees.
- The Accession/RSC acquisition (closed in 2025) raised revenue and debt at the same time: ROIC on total capital falls structurally because the denominator now carries the price paid in goodwill.
- Organic growth went from +2.8% in 2025 to −0.7% in the second quarter of 2026: the price-and-volume mix is softening in the property and casualty insurance cycle.
Intrinsic value — two valuation methods
Total return at 5 years: 9.3%/year = 8.2% appreciation + 1.0% dividend. The target price ($109) is ex-dividend; the $4 in dividends collected over 5 years are added separately.
By both methods, the value today (DCF $149 · Multiples $91) exceeds the market price ($73).
Pillars of the analysis
The verdict — today vs 5 years
Today — fairly valued: at $73 trades ~19.7% below its value discounted to today (~$91); the discount is positive but does not reach the margin of safety we require (≥38%).
At 5 years — En valor: the target price ($109) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.
The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$57.
Thesis
The business
Asset-light insurance broker, diversified by client and by insurer, with a moat of relationships and niche technical expertise, but with organic growth that turned negative just as the company absorbs the debt from its largest historical acquisition.
The valuation
Valued by sum of the parts: Retail and Specialty Distribution, each at a multiple within the [16x,22x] band of comparable earnings proper to the insurance-brokerage archetype, weighted by each segment's contribution to terminal earnings. The five-year result is $109 per share, versus a price of $73, for a total return of +9% annually (+8% of appreciation plus +1% of dividend).
The margin of safety
It trades close to intrinsic value, far from the required margin of safety. The adverse scenario penalizes the persistence of negative organic growth and compresses the multiple toward the floor of the band; the favorable scenario assumes the insurance pricing cycle hardens again and the Accession integration unlocks synergies, expanding the multiple toward the ceiling.
What to watch
The central disconfirmer is whether the negative organic growth of 2026 is transitory (cyclical price softening) or structural (share loss to competitors or disintermediation). A third consecutive quarter of negative organic revenue, with no sign of price hardening, would invalidate the thesis that the weakness is temporary.
Educational / informational. Does not constitute investment advice.